Expert Insight
AI and Digital Maturity in Biopharma Contract Manufacturing: Key Findings from Research
Watch the presentation of the results with MasterControl
9 December 2025
Expert Insight
The Six Pillars of Supplier Relationship Management
In pharmaceutical manufacturing, the complexity of outsourcing relationships demands a systematic approach. As external manufacturing networks grow more critical to business success, organizations need a clear framework to guide their supplier management programmes. Each year, State of Flux’s Global SRM
5 December 2025
Expert Insight
Robust Analytics for Novel Modalities: Industry Leaders Share Strategies
As cell and gene therapies, RNA-based platforms, and antibody-drug conjugates accelerate toward commercialization, the pharmaceutical industry must develop analytical methods robust enough to characterize increasingly complex therapeutic modalities while remaining flexible enough to evolve with emerging science. PharmaSource asked analytical
3 December 2025
Expert Insight
How to negotiate CDMO Contracts for Flexibility and Cost Control
As clinical development timelines compress and therapeutic complexity rises, pharmaceutical sponsors must secure manufacturing partnerships that adapt to uncertainty without draining budgets. How to structure CDMO contracts that deliver both flexibility and cost efficiency has become a strategic imperative and
25 November 2025
Expert Insight
Strategic Dual Sourcing: Risk Mitigation Without Complexity
In an era of persistent supply chain disruptions, how can pharmaceutical and biotech companies protect against single-source vulnerabilities without drowning in operational complexity? Six industry leaders recently weighed in on dual sourcing strategies, offering a roadmap for executives seeking resilient
20 November 2025
Expert Insight
MilliporeSigma Expands Protein A Portfolio to Tackle mAbs Challenges
MilliporeSigma is betting on advanced chromatography capabilities to address persistent bottlenecks in antibody manufacturing as the company prepares to integrate JSR Life Sciences’ Protein A resin technology into its bioprocessing portfolio. The acquisition, announced in October 2025 with an expected
13 November 2025
Expert Insight
Patient Access Barriers Drive GLP-1 Development Strategies
At Nordic Life Science Days (NLSDays), leading pharmaceutical executives from Novo Nordisk, AstraZeneca, and Roche convened to discuss the evolving landscape of cardiovascular, renal, and metabolic (CVRM) drug development. The “Transforming CVRM Health” panel revealed that despite clinical successes with
29 October 2025
Expert Insight
What Industry Leaders Say About the Future of CDMO Partnerships
The relationship between pharmaceutical companies and their manufacturing partners is changing. At CPHI Frankfurt 2025, industry leaders outlined a new approach to CDMO selection and management during the talk, “CDMOs at a Crossroads: Scaling, Adapting, and Partnering for the Future.”
28 October 2025
Expert Insight
How Pharma Can Accelerate Scope 3 Decarbonization Through Supply Chain Partnerships
Decarbonization is a business imperative requiring stronger collaboration among providers, manufacturers, and suppliers. The PSCI Decarbonization Summit 2025 brought together leaders across the pharma value chain to share strategies and to advance decarbonization. The closing panel featured Cristina Indiveri, AVP
27 October 2025
Expert Insight
How Pharma Companies Are Actually Embedding Climate Standards in Their Supply Chains
Most pharma companies have climate commitments. Far fewer have woven those standards into how they select, onboard, and work with suppliers. At the PSCI Decarbonization Summit 2025, Koen Postuma, Director of Procurement at Merck, Vincent Barbotin, Scope 3 Active Ingredient
24 October 2025